Copyright
©The Author(s) 2018.
World J Gastroenterol. Apr 21, 2018; 24(15): 1591-1600
Published online Apr 21, 2018. doi: 10.3748/wjg.v24.i15.1591
Published online Apr 21, 2018. doi: 10.3748/wjg.v24.i15.1591
< 1 yr | 1-3 yr | 3-10 yr | > 10 yr | P value | |
H. pylori infection rate | 23.8 (15/63) | 16.7 (18/108) | 15.0 (34/226) | 7.8 (8/13) | 0.043 |
Rate of H. pylori negatives | 55.5 (35/63) | 62.0 (67/108) | 68.1 (154/226) | 68.9 (71/103) | > 0.05 |
Year | Author | Country | n | Regimen | Treatment period | Eradication rate (%) | Analytic methods |
1997 | Tamura et al[61] | Japan | 14 | LPZ (30) oid/ 8 wk, AMPC (500) oid/ 3 wk, plaunotol (80) tid/ 24 wk | 21 d | 78.6 | RUT, Culture, Histology |
1998 | Munos de Bustillo E et al[30] | Spain | 23 | OPZ (20) bid, AMPC (500) tid | 14 d | 60.8 | UBT |
23 | plus OPZ (20) bid, CAM (500) bid | 14 d | 82.6 | ||||
1998 | Tokushima et al[62] | Japan | 17 | LPZ (30) oid/ 8 wk, AMPC (500) | 21 d | 76.5 | RUT, Culture, Histology |
10 | LPZ (30) oid, AMPC (250), MNZ (250) bid/ | 7 d | 90 | ||||
1999 | Araki et al[63] | Japan | 17 | OPZ (20) oid/ 8 wk, AMPC (250) oid, CAM (200) oid/ 3 wk, polaprizinc (0.5) bid/ 24 wk | 21 d | 88.2 | IgG, Histology |
1999 | Gur et al[11] | Turkey | 25 | FAM (40) oid, CAM (500) bid, MNZ (250) bid | 15 d | 80 | Histology, RUT |
2001 | Wang et al[64] | China | 38 | OPZ (20), AMPC (1000), CAM (500) bid | 7 d | 86.8 | Stool |
2002 | Mak et al[91] | China | 21 (CRF) | OPZ (20), AMPC (1000), CAM (500) bid | 7 d | 90.5 | RUT |
2002 | Tsukada et al[65] | Japan | 39 | OPZ (30) bid, AMPC (500) tid, CAM (400) bid | 7 d | 82.1 | UBT |
2003 | Mak et al[92] | China | 25 (CRF) | OPZ (20) or LPZ (30), AMPC (1000), CAM (500) bid | 7 d | 96 | Histology |
2003 | Sheu et al[67] | China | 38 (CRF) | LPZ (30), AMPC (750), CAM (500) bid | 7 d | 76.3 | |
40 (CRF) | LPZ (30), CAM (500), MNZ (500) bid | 7 d | 92.5 | Stool | |||
2004 | Sezer et al[4] | Turkey | 17 | OPZ (20), AMPC (1000), CAM (500) bid/ | 14 d | 94.1 | Endoscopy |
2007 | Tseng et al[93] | China | 34 (CRF) | ESO (40) or OPZ (20) bid, AMPC (1000) bid, CAM (500) bid | 7 d | 94.1 | UBT |
2007 | Itatsu et al[69] | Japan | 11 | LPZ (60), AMPC (750), CAM (400) | 7 d | 72.7 | RUT |
9 | LPZ (60), CAM (400) | 7 d | 33.3 | ||||
2010 | Change et al[70] | Korea | 12 | OPZ (20), AMPC (250), CAM (250), bid | 7 d | 83.4 | RUT, Histology |
2010 | Jalalzadeh et al[94], Falaknazi et al[95] | Iran | 37 | OPZ (20), AMPC (1000), CAM (250), bid | 14 d | 81.1 | IgG, UBT, Stool |
2012 | Seyyedmajidi et al[96], Jalalzadeh et al[97,98] | Iran | 17 | OPZ (20), AMPC (500), CAM (250), bid | 14 d | 82.4 | UBT, Stool |
Vafaeimanesh et al[99] | |||||||
20 | OPZ (40), AMPC (500), azithromycin (250), bid | 14 d | 80 | ||||
2014 | Makhlough et al[100] | Iran | 21 | PPZ (40), AMPC (500), CAM (250), bid | 14 d | 66.7 | RUT, Histology |
24 | Sequential therapy (PPT [40] 10 d, AMPC (500) bid, 5 d and CAM (250), tinidazole (500), bid, 5 d | 10 d | 84 | ||||
2016 | Makhlough et al[101] | Iran | 20 | PPZ (40), AMPC (500), CAM (500), bid | 14 d | 70 | RUT, Stool |
20 | Hybrid regimen PPZ (40), AMPC (500), bid, 7 d + PPZ (40), AMPC (500), CAM (500), tinidazole (500), bid, 7 d | 14 d | 100 | ||||
2018 | Sahara et al[55] | Japan | 18 | ESO (20), AMPC (750), CAM (200) bid | 7 d | 77.8 | IgG |
19 | ESO (20), AMPC (250), CAM (200) bid | 7 d | 84.2 |
Atrophy (-) | Atrophy (+) | P-value | |
N (Male/Female) | 28 (17/11) | 50 (33/17) | - |
Age | 67.7 ± 12.3 | 71.6 ± 11.0 | 0.155 |
Dialysis periods (yr) | 7.5 (2.4-16.8) | 7.7 (3.1-12.7) | 0.681 |
Acyl-ghrelin | 38.0 (23.5-57.0) | 18.0 (12.0-26.3) | < 0.001 |
Desacyl-ghrelin | 303 (248-533) | 200 (137-277) | < 0.001 |
BMI (kg/m2) | 19.8 ± 3.2 | 19.6 ± 2.8 | 0.773 |
Albumin (g/dL) | 3.5 ± 0.3 | 3.4 ± 0.4 | 0.273 |
Total cholesterol (mg/dL) | 166 ± 37 | 154 ± 36 | 0.165 |
Cholinesterase (U/L) | 245 ± 111 | 219 ± 68.7 | 0.205 |
Intact PTH (pg/mL) | 351 ± 294 | 247 ± 192 | 0.062 |
Ferritin (ng/mL) | 128 ± 118 | 128 ± 221 | 0.989 |
PG I (ng/mL) | 416.2 (314.2-783.7) | 196.0 (73.8-358.8) | < 0.001 |
PG II (ng/mL) | 42.3 (31.6-60.0) | 28.4 (16.8-45.7) | 0.003 |
PG I/II ratio | 10.89 (9.11-13.38) | 7.31 (4.17-11.08) | 0.001 |
nPCR (g/kg/d) | 0.94 ± 0.14 | 0.85 ± 0.16 | 0.022 |
- Citation: Sugimoto M, Yasuda H, Andoh A. Nutrition status and Helicobacter pylori infection in patients receiving hemodialysis. World J Gastroenterol 2018; 24(15): 1591-1600
- URL: https://www.wjgnet.com/1007-9327/full/v24/i15/1591.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i15.1591